NewsVoir Mumbai Maharashtra [India]2 Lung cancer remains one of the most prevalent and deadly cancers globally with approximately 22 million new cases diagnosed annually contributing to 18 of all canc ...

Japanese drugmaker Takeda (TYO: 4502) has launched Fruzaqla (fruquintinib) in its home country. This follows the approval of ...

Metropolis molecular genomics study shows genetic profiling are improving survival rates: Our Bureau, Bengaluru Friday, November 22, 2024, 14:45 Hrs [IST] Metropolis Healthcare co ...

Takeda said in September 2024 that it received approval from the Japanese Ministry of Health, Labour and Welfare to manufacture and market FRUZAQLA Capsules 1mg/5mg, a selective oral inhibitor of ...

Sarrah Strimel Bentley is an optimist – even when it comes to her journey with early breast cancer. The new mother and philanthropist discusses why she’s empowered to live a happy and healthy life.

ImmunityBio has partnered with nCartes to automate and expedite the data fulfilment process for clinical trials.

Affimed (NASDAQ:AFMD – Get Free Report) has earned a consensus rating of “Moderate Buy” from the five research firms that are presently covering the firm, MarketBeat reports. One research analyst has ...

Empowered Funds LLC lessened its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 79.8% during the third quarter, Holdings Channel reports. The firm owned 22,081 shares of the ...

The human epidermal growth factor receptor 2 (HER2) is a well-validated target for antitumor therapy in other cancers. Across the US, Europe, and Japan, approximately 12,000 people are diagnosed with ...

Australian women have been raving about a 'beautiful' anti-ageing skincare serum that transforms their skin, with many ...

Though this biotech’s progress with its obesity drug program has been encouraging, the rising competition for developing ...